Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Ovarian Cancer Recurrent 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Tocotrienols × Clear all
NCT04175470 2025-01-03

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Vejle Hospital

Phase 2 Completed
20 enrolled
Gynecologic

Ovarian Cancer Recurrent

NCT02705300 2024-08-29

Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

Vejle Hospital

Phase 2 Completed
70 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02909751 2021-05-20

NeoToc

Vejle Hospital

Phase 2 Completed
80 enrolled
Breast

Breast Neoplasms

NCT04496492 2020-08-03

TOCANNATO

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡